HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?
- 31 January 2004
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 40 (1), 56-63
- https://doi.org/10.1016/j.ejca.2003.08.027
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Recommendations for HER2 testing in the UKJournal of Clinical Pathology, 2000
- Genetic alterations and biological pathways in human bladder cancer pathogenesisUrologic Oncology, 2000
- NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- c-erbb-2 gene amplification as a prognostic marker in human bladder cancerUrology, 2000
- Numeric aberration of chromosome 17 is strongly correlated with p53 overexpression, tumor proliferation and histopathology in human bladder cancer.International Journal of Urology, 1998
- Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?British Journal of Cancer, 1998
- C-ERBB-2 in Bladder Cancer: Molecular Biology, Correlation with Epidermal Growth Factor Receptors and Prognostic ValueJournal of Urology, 1996
- An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinomaCancer, 1992
- The Role of Adjuvant Chemotherapy Following Cystectomy for Invasive Bladder Cancer: A Prospective Comparative TrialJournal of Urology, 1991
- Expression of C-ERBB-2 Gene Product in Urinary Bladder CancerJournal of Urology, 1991